StreetInsider.com News Articles

Form 4 BillionToOne, Inc. For: Oct 13 Filed by: Lynch Thomas P.

Mon, 19 Oct 2026 19:35:00 -0400

si-local-file:///var/storage/secattach/20261019/27205048.html

Form 4 BillionToOne, Inc. For: Oct 14 Filed by: Atay Oguzhan

Fri, 16 Oct 2026 19:00:00 -0400

si-local-file:///var/storage/secattach/20261016/27198946.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Thu, 15 Oct 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20261015/27193845.html

Form 4 BillionToOne, Inc. For: Oct 12 Filed by: Atay Oguzhan

Wed, 14 Oct 2026 18:10:00 -0400

si-local-file:///var/storage/secattach/20261014/27188077.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Wed, 14 Oct 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20261014/27187369.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Wed, 14 Oct 2026 12:33:00 -0400

si-local-file:///var/storage/secattach/20261014/27186199.html

BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026

Wed, 14 Oct 2026 08:05:00 -0400

MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, November 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.

Analysts planning to participate in the conference call should register here

BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026

Wed, 14 Oct 2026 08:05:00 -0400

Analysts planning to participate in the conference call should register here

Form 4 BillionToOne, Inc. For: Oct 08 Filed by: Lynch Thomas P.

Tue, 13 Oct 2026 18:40:00 -0400

si-local-file:///var/storage/secattach/20261013/27182198.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Tue, 13 Oct 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20261013/27178335.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Tue, 13 Oct 2026 08:51:00 -0400

si-local-file:///var/storage/secattach/20261013/27178078.html

Form 4 BillionToOne, Inc. For: Oct 05 Filed by: ten Bosch John Roderick

Wed, 07 Oct 2026 19:57:00 -0400

si-local-file:///var/storage/secattach/20261007/27162264.html

Form 4 BillionToOne, Inc. For: Oct 05 Filed by: Tsao David

Wed, 07 Oct 2026 19:56:00 -0400

si-local-file:///var/storage/secattach/20261007/27162263.html

BillionToOne cancer monitoring test matches tumor-informed assay in study

Wed, 07 Oct 2026 07:02:13 -0400

BillionToOne, Inc. (Nasdaq: BLLN) announced the publication of a peer-reviewed study comparing its Northstar Response liquid biopsy assay against a commercially available tumor-informed circulating tumor DNA (ctDNA) test for monitoring cancer treatment in advanced-stage patients.

The retrospective real-world study, published in The Journal of Liquid Biopsy, evaluated 169 paired samples from 61 patients. Of those, 71 samples from 36 patients had sequential concurrent draws collected within seven days of each other. Quantitative results showed close alignment between the two assays, with a conditional R² of 0.97. The two approaches reached the same conclusion on the direction of change in tumor burden

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

Wed, 07 Oct 2026 07:00:00 -0400

Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response

MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced the publication of the first peer-reviewed head-to-head study comparing Northstar Response®, a tissue-free, methylation-based liquid biopsy assay utilizing patented single-molecule counting technology to measure the absolute number of circulating tumor DNA (ctDNA) molecules, with a commercially available tumor-informed ctDNA assay for advanced cancer patients

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

Wed, 07 Oct 2026 07:00:00 -0400

Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response

Form 144 BillionToOne, Inc. Filed by: Tsao David

Mon, 05 Oct 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20261005/27148880.html

Form 144 BillionToOne, Inc. Filed by: ten Bosch John Roderick

Mon, 05 Oct 2026 13:46:00 -0400

si-local-file:///var/storage/secattach/20261005/27148085.html

Form 144 BillionToOne, Inc. Filed by: Tsao David

Mon, 05 Oct 2026 10:50:00 -0400

si-local-file:///var/storage/secattach/20261005/27147267.html

BillionToOne Inc (BLLN) PT Raised to $128 at Guggenheim

Thu, 01 Oct 2026 08:47:44 -0400

Guggenheim analyst Subbu Nambi raised the price target on BillionToOne Inc (NASDAQ: BLLN) to $128.00 (from $125.00) while maintaining a Buy rating.

Form 4 BillionToOne, Inc. For: Sep 28 Filed by: Atay Oguzhan

Wed, 30 Sep 2026 20:33:00 -0400

si-local-file:///var/storage/secattach/20260930/27129903.html

Form 4 BillionToOne, Inc. For: Sep 24 Filed by: ten Bosch John Roderick

Mon, 28 Sep 2026 17:57:00 -0400

si-local-file:///var/storage/secattach/20260928/27115708.html

Form 4 BillionToOne, Inc. For: Sep 24 Filed by: Tsao David

Mon, 28 Sep 2026 17:57:00 -0400

si-local-file:///var/storage/secattach/20260928/27115709.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Mon, 28 Sep 2026 11:37:00 -0400

si-local-file:///var/storage/secattach/20260928/27112037.html

Form 144 BillionToOne, Inc. Filed by: Atay Oguzhan

Mon, 28 Sep 2026 11:30:00 -0400

si-local-file:///var/storage/secattach/20260928/27112006.html